Long-term risks of Trulicity include the potential worsening of or new onset kidney damage and severe digestive problems such as gastroparesis or ileus
The test should be interpreted with a qualified healthcare provider in the context of your clinical history, TSH levels, and current medications
Your provider must document BMI, relevant comorbidities (diabetes, hypertension, cardiovascular markers), and why GLP-1 therapy aligns with clinical guidelines
Identifying Suitable Candidates for Semaglutide You might be a suitable candidate for semaglutide weight loss treatment if your BMI is 30 or higher, or 27 or higher with a weight-related medical condition like high blood pressure, type 2 diabetes, or elevated cholesterol
8523, revised 2011) and the ARRIVE guidelines